Genmab A (GMAB) Change in Intangibles (2023 - 2025)
Genmab A (GMAB) posted Change in Intangibles of -$18.0 million for Q3 2025, little changed on a QoQ basis from -$18.0 million in Q2 2025, and down 800.0% year-over-year from $2.6 million in Q3 2024.
Genmab A (GMAB) Change in Intangibles (2023 - 2025) Analysis & Trends
Genmab A's Change in Intangibles history runs 3 years deep, the most recent figure standing at -$18.0 million for Q3 2025.
- Quarterly Change in Intangibles fell 800.0% year-over-year to -$18.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$71.0 million (changed N/A YoY) and the FY2025 annual result came in at -$18.0 million, down 5.88% from the prior year.
- Change in Intangibles was -$18.0 million for Q3 2025 at Genmab A, roughly flat from -$18.0 million in the prior quarter.
- Across five years, Change in Intangibles topped out at -$1.0 million in Q4 2023 and bottomed at -$18.0 million in Q1 2025.
- A 3-year average of -$12.3 million and a median of -$17.5 million in 2024 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2024 — Change in Intangibles tumbled 1600.0% — and 2025, when it tumbled 800.0%.
- Genmab A's Change in Intangibles stood at -$1.0 million in 2023, then tumbled by 1600.0% to -$17.0 million in 2024, then declined by 5.88% to -$18.0 million in 2025.
- Business Quant data shows GMAB's Change in Intangibles at -$18.0 million in Q3 2025, -$18.0 million in Q2 2025, and -$18.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -66,508.31 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -18.00 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -18.00 Mn |
| Mar 31, 2025 | -18.00 Mn |
| Mar 31, 2025 | -18.00 Mn |
| Dec 31, 2024 | -17.00 Mn |
| Dec 31, 2024 | -17.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |